Rational Design of Cancer-Targeted Benzoselenadiazole by RGD Peptide Functionalization for Cancer Theranostics

产品简述

期刊
Macromolecular Rapid Communications


标题
Rational Design of Cancer-Targeted Benzoselenadiazole by RGD Peptide Functionalization for Cancer Theranostics


作者
Liye Yang, Wenying Li, Yanyu Huang, Yangliang Zhou and Tianfeng Chen


摘要
A novel cancer-targeted prodrug BSeC-PEI-RGD with RGD peptide-conjugated selenocompound BSeC using PEI polymer as a linker is rationally designed and synthesized. BSeC-PEI-RGD shows selective cytotoxicity against cancer cells through induction of apoptosis with the involvement of intrinsic and extrinsic pathways. Moreover, the green fluorescence of BSeC-PEI-RGD supports its application potential in cancer diagnosis.


原文链接
http://onlinelibrary.wiley.com/doi/10.1002/marc.201500243/abstract


2017年02月09日

添加时间:

​Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation (ChemMedChem 6/2015) (page 934)

上一个:

下一个:

Manipulation of the Aggregation and Deaggregation of Tetraphenylethylene and Silole Fluorophores by Amphiphiles: Emission Modulation and Sensing Applications
  • 1